*VALUING YOUR MEDICAL PRACTICE For Sale* | Poll: Selling Your Practice and Retiring — Where/To what type of entity are you planning to sell or getting offers from?
FOR IMMEDIATE RELEASE
Contact: Craig Zevin, UBERDOC, Inc
Boston-based Consumer Health App for Direct-Pay Healthcare Partners with MyRx365 to Provide Patients Access to Pharmacy Prescriptions at a Transparent Price
Boston, MA–August 18, 2020—UBERDOC, Inc. (“UBERDOC”) and MyRx365 are pleased to announce a strategic partnership that combines UBERDOC’s price-transparent patient platform with MyRx365’s consumer pharmacy services to provide holistic, price-transparent healthcare. Starting in September 2020, patients will be able to see doctors, order prescriptions, and pay cash for care directly from a single platform.
Price transparency in healthcare is a rapidly growing concern for consumers as out-of-pocket costs rise and families nation-wide lose access to their employer-based healthcare. Many consumers actively avoid seeking the healthcare they need due to their fear of “surprise bills” that come with every visit. The UBERDOC-MyRx365 partnership ensures that every person in the country has on-demand access to top doctors and prescriptions for a fixed price, regardless of their insurance status.
“UBERDOC’s mission is to provide patients with equitable access to healthcare at transparent, affordable prices. Recognizing that prescriptions account for a significant portion of the cost of care, we’ve partnered with MyRx365 to ensure our mission extends beyond the conventional “walls” of a doctor’s office. Now patients can schedule an appointment, receive care via telemedicine, and have prescriptions delivered to their door, all from a single platform for a flat price.” said Dr. Paula Muto, CEO, and founder of UBERDOC.
MyRx365 is a centralized hub for a patient’s healthcare data and includes digital pharmacy solutions for prescription delivery. Their online and app-based tools allow consumers to stay engaged in their care plan and maintain adherence. Addressing COVID-19 concerns, MyRx365 offers a telemedicine platform that allows patients to talk directly with a pharmacist, as well as the ability to schedule convenient delivery times to eliminate in-person medication pick-ups.
“MyRx365 focuses on the bigger picture of price transparency for doctor visits and prescription drugs,” says Dr. Mohammad Ali, founder, and CEO of MyRx365. “Combining UBERDOC with MyRx365 allows two physician-owned companies to come together to solve the biggest challenges facing patients today–especially with rising unemployment and poor economy. By providing patients with ownership of their health information and giving them insights into transparent pricing, the patient comes out ahead.”
As a sign of their investment in the partnership, MyRx365 has also participated in UBERDOC’s current round of venture funding.
About UBERDOC, Inc.
Established in 2016, UBERDOC is a technology marketplace where patients and doctors can connect for affordable, transparently priced care. UBERDOC’s mobile-enabled tools allow doctors to build custom “digital offices” that serve the needs of their patients on a fixed pricing model. The platform currently offers in-person care, telemedicine, remote patient monitoring, credentialing, and digital eye exams with more partnerships being added each month. The Boston-based, privately held company, founded by Paula Muto, MD, FACS, a vascular and general surgeon, is owned and operated by a majority female team.
MYRX365 is a digital health company focusing on patients with chronic diseases. MyRx365 integrates with a number of data sources to create a 360 degree of a patient’s health. Using predictive analytics and machine learning, MyRx365 is able to increase patient engagement and decrease costs to the health system as a whole. The company’s unique suite of technology tools effectively creates a real-time care triangle, linking patients, providers, and the pharmacy to maximize engagement and adherence. MyRx365, founded by Mohammad Ali, MD, MS is a physician funded company based in NYC.